A61K 38/4866
Protein c
Official title: {Protein C (3.4.21.69)}
A61K38/4866 (Protein c) appears on 84 US grants and 142 published applications in this corpus.
Search patents in A61K- Granted patents
- 84
- Published applications
- 142
- Assignees
- 56
- Inventors
- 213
- Latest grant
- 20 Jan 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 2 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 2 | 0 |
| 1998 | 1 | 0 |
| 1999 | 2 | 0 |
| 2000 | 5 | 0 |
| 2001 | 4 | 6 |
| 2002 | 6 | 3 |
| 2003 | 2 | 6 |
| 2004 | 4 | 7 |
| 2005 | 3 | 4 |
| 2006 | 2 | 5 |
| 2007 | 2 | 5 |
| 2008 | 0 | 8 |
| 2009 | 2 | 4 |
| 2010 | 1 | 12 |
| 2011 | 0 | 5 |
| 2012 | 3 | 5 |
| 2013 | 4 | 8 |
| 2014 | 5 | 6 |
| 2015 | 4 | 9 |
| 2016 | 0 | 3 |
| 2017 | 4 | 8 |
| 2018 | 1 | 7 |
| 2019 | 7 | 4 |
| 2020 | 4 | 11 |
| 2021 | 3 | 3 |
| 2022 | 5 | 4 |
| 2023 | 2 | 4 |
| 2024 | 1 | 3 |
| 2025 | 2 | 1 |
| 2026 | 1 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Protein C zymogen and methods of use thereof to prevent cancer metastases20 Jan 2026US 12,527,848 B2The Children’s Hospital of Philadelphia
- Peptides for treatment and prevention of diabetes and associated disorders20 May 2025US 12,303,556 B2Inserm (Institut National De La Sante Et De La Recherche Medicale)
- Use of APC analogue for wound healing4 Feb 2025US 12,214,024 B2ZZ Biotech LLC
- Method of targeting exosomes14 May 2024US 11,981,723 B2Gladiator Biosciences, Inc.
- Conjugates of tumor necrosis factor inhibitors to functionalized polymers15 Aug 2023US 11,723,981 B2QuiaPEG Pharmaceuticals AB
- Improved downregulation of histone cytotoxicity by complex of negatively charged polysaccharide and protease3 Sep 2026US 2026/0256895 A1Academisch Ziekenhuis Maastricht
- Sequence of activated protein c5 Jun 2025US 2025/0177571 A1Jichi Medical University
- Methods for the measurement of protein c and activated protein c14 Nov 2024US 2024/0377410 A1
- Anti-fibrosis pharmaceutical composition and application thereof26 Sep 2024US 2024/0316011 A1West China Second University Hospital
- Conjugates of tumor necrosis factor inhibitors to functionalized polymers7 Mar 2024US 2024/0075151 A1QuiaPEG Pharmaceuticals AB
Most cited
By later US patents
- Implantable system with drug-eluting cells for on-demand local drug delivery296US 6,206,914 B1Medtronic, Inc. · 2001
- Implantable system with drug-eluting cells for on-demand local drug delivery131US 6,824,561 B2Medtronic, Inc. · 2004
- Activated protein C formulations51US 6,436,397 B1Eli Lilly and Company · 2002
- Methods for treating thrombotic disorders49US 6,071,514 AEli Lilly and Company · 2000
- Further use of protein kinase N beta46US 7,713,943 B2Silence Therapeutics GmbH · 2010